Radiologist - Nuclear Medicine

About the Role

The Department of Radiology at the Penn State University College of Medicine is seeking a full-time Faculty Physician for the Division of Nuclear Medicine. The successful candidate will be subspecialty trained and have or be eligible for either a CAQ in nuclear medicine from the ABR or ABNM certification.

Special consideration will be given to candidates with an academic interest in oncologic imaging, theranostics, and neuromolecular imaging in neurocognitive diseases. There is an opportunity for interdisciplinary clinical research through collaboration with basic science investigators on Penn State University’s main campus and at the Center for NMR Research and MRI Core Research facility.

The Department has a strong commitment to serve the clinical, education, and research mission of the University and maintains a collegial and collaborative relationship with clinical services. A passion for teaching is essential, as educating medical students, residents, fellows, and staff is a core value of the academic mission.

Responsibilities

• Interpretation of diagnostic adult and pediatric nuclear medicine examinations
• Consultation for and supervision of therapeutic procedures

Facilities and Equipment

The Division of Nuclear Medicine has state-of-the-art diagnostic imaging equipment, including:

• One PET/CT scanner (Biograph mCT) – features include a diagnostic 16-slice CT scanner with images reviewed on Syngo.via and on Philips IntelliSpace PACS
• Two modern Symbia Intevo hybrid SPECT/CT systems – features include a diagnostic 16-slice CT scanner combined with a dual-headed SPECT gamma camera; XSPECT and XQUANT; provides precise anatomic localization to guide diagnostic and therapeutic interventions
• Three dual-head SPECT gamma cameras
• One dedicated cardiac SPECT gamma camera
• Atom 950 thyroid uptake system
• Two Hologic Horizon A bone densitometers
• One Hologic Discovery A bone densitometer

Unique facilities include an ultramodern USP 797 compliant nuclear pharmacy permitting on-site radiopharmaceutical compounding.

Regionally Unique Services

Therapeutic Services

• PLUVICTO™ (lutetium Lu177 vipivotide tetraextan) – targeted radiotherapy for men with PSMA positive advanced metastatic prostate cancer. Penn State Hershey was one of three initial hospitals in Pennsylvania to offer this novel treatment beginning in July 2022
• LUTATHERA™ (lutetium Lu177 dotatate) – a targeted radiotherapy for patients with somatostatin receptor positive low-to-intermediate grade gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
• Xofigo™ (radium Ra 223 dichloride) – for treatment of castrate-resistant prostate cancer that is metastatic to bone
• Y-90 selective internal radiation therapy – performed in conjunction with the interventional radiology service for treatment of hepatic cancers and liver metastasis

Diagnostic Services

• CERIANNA™ (fluoroestradiol F18) – targeted PET/CT imaging study for Estrogen receptor positive breast carcinoma and lobular breast carcinoma. Introduced in November 2021
• PYLARIFY™ (piflufolastat F18) and LOCAMETZ™ (gallium Ga68 gozetotide) – targeted PET/CT imaging for localization of PSMA receptor positive lesions in prostate cancer. Introduced in November 2021 and March 2022, respectively
• NETSPOT (gallium Ga68 dotatate) and DETECTNET™ (copper Cu64 dotatate) – PET imaging for localization of somatostatin receptor positive neuroendocrine tumors
• AMYVID® (fluorbetapir F18) – PET imaging for estimating beta amyloid neuritic plaque density for patients with cognitive impairment who are being evaluated for Alzheimer’s Disease and other causes of cognitive decline
• PET myocardial Perfusion Imaging – initiated in February 2021
• PET imaging for cardiac sarcoidosis
• Tc-99m pyrophosphate imaging for the detection of transthyretin cardiac (ATTR) amyloidosis
• DaTscan™ (ioflupane I123) – imaging for evaluation of patients with suspected parkinsonian disorders

Education and Research

The Division of Nuclear Medicine has 3 fellowship-trained faculty and sponsors an ACGME fellowship in nuclear medicine and molecular imaging. The Center for NMR Research and MRI Core Research facility has 4 research faculty with unique expertise in applying fMRI and quantitative imaging biomarkers to study neurocognitive diseases and brain trauma.

The Department recently established an imaging core lab to support the development and application of imaging biomarkers for clinical research and the Division of Radiology Innovation and Value Enhancement (DRIVE) for support of informatics and advanced data analytics for research and process improvement.

Location

Hershey, PA is a town of 15,000 residents and part of the greater metropolitan Harrisburg area within 2 hours of Washington D.C., Baltimore, and Philadelphia. The area offers excellent schools, a safe and friendly environment, outdoor sports opportunities, and a commute time of 5–10 minutes, making it ideal for a family-friendly active life in Central PA.

For additional information, contact Nicole Brandt at nbrandt@pennstatehealth.psu.edu.